What is Amphastar Pharmaceuticals's debt repayments?

Amphastar Pharmaceuticals (AMPH) reported debt repayments of $29K in Q1 2026.

How has Amphastar Pharmaceuticals's debt repayments changed year-over-year?

Amphastar Pharmaceuticals's debt repayments decreased by 23.7% year-over-year, from $38K to $29K.

What is the long-term trend for Amphastar Pharmaceuticals's debt repayments?

Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's debt repayments has grown at a -72.1% compound annual growth rate (CAGR), from $36.74M to $223K.

What does debt repayments mean?

Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.

Amphastar Pharmaceuticals AMPH Debt Repayments

Debt Repayments at other companies

Opko HealthOPK

$8.88M-7.0%

AptarGroupATR

$127.93M+2,710%

Axsome TherapeuticsAXSM

$70M—

BrightSpring Health Services, Inc.BTSG

$12.35M+4.8%

Becton, Dickinson and CompanyBDX

$2B—

Cardinal HealthCAH

$113M+927%

Other financials

Income statement

See full

Revenue$171.2M+0.4%

Gross profit$70.3M-17.5%

Operating income$13.6M-63.5%

Net income$6.4M-74.6%

EPS (diluted)$0.14-72.5%

Balance sheet

See full

Cash & equivalents$170.9M-6.5%

Total debt$686.6M+5.2%

Total equity$445.5M—

Total assets$1.6B+1.3%

Cash flow

See full

Operating cash flow$47.8M+36.4%

CapEx$9.5M-11.1%

Free cash flow$38.3M+57.2%

Valuation

See full

Market cap$926.83M-19.9%

Enterprise value$1.44B-11.3%

P/E11.7×+3.5×

P/S1.3×-0.3×

Profitability

See full

Gross margin47.3%-3.2pp

Operating margin16.2%-10.4pp

Net margin11%-8.4pp

FCF margin18.8%-1.8pp

Returns & leverage

See full

Return on equity14.7%—

Debt / equity0.2×—

Current ratio3.9×+0.9×

Where this comes from

Reported directly by Amphastar Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amphastar Pharmaceuticals's debt repayments?: Amphastar Pharmaceuticals (AMPH) reported debt repayments of $29K in Q1 2026.
How has Amphastar Pharmaceuticals's debt repayments changed year-over-year?: Amphastar Pharmaceuticals's debt repayments decreased by 23.7% year-over-year, from $38K to $29K.
What is the long-term trend for Amphastar Pharmaceuticals's debt repayments?: Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's debt repayments has grown at a -72.1% compound annual growth rate (CAGR), from $36.74M to $223K.
What does debt repayments mean?: Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.